Loading
NI
Neurologix Inc/de Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Nickels Craig J, was filed 12 Jun 2008.
Neurologix Inc/de: what insiders have been doing
Neurologix Inc/de is a listed company. Its directors and officers file their transactions with SEC (Form 4). Neurologix Inc/de has had no insider filing for more than a year; the last one goes back to 12 June 2008.
Since 2006, the database holds 18 purchases and 26 sales by insiders of the company.
These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Insider Decl.
45
Thresholds
n/a
Buy Volume
€165,386
18 ops. · all time
Sell Volume
€93,444
26 ops. · all time
Last declaration on 12 June 2008
Declarations45 total
9,500 shares@ US$0.60Common StockSEC:0001193805-08-001567:0
Canonical exit: 9 Sept 2008 (T+90)
2,500 shares@ US$0.59Common StockSEC:0001193805-08-001567:1
Canonical exit: 9 Sept 2008 (T+90)
20,000 shares@ US$0.62Common StockSEC:0001193805-08-001503:0
Canonical exit: 1 Sept 2008 (T+90)
5,588 shares@ US$0.65Common StockSEC:0001193805-08-001496:0
Canonical exit: 31 Aug 2008 (T+90)
8,000 shares@ US$0.62Common StockSEC:0001193805-08-001445:0
Canonical exit: 26 Aug 2008 (T+90)
20,000 shares@ US$0.80Common StockSEC:0001193805-08-001402:0
Canonical exit: 17 Aug 2008 (T+90)
25,000 shares@ US$0.77Common StockSEC:0001193805-08-001393:0
Canonical exit: 14 Aug 2008 (T+90)
5,900 shares@ US$0.60Common StockSEC:0001193805-08-001378:0
Canonical exit: 13 Aug 2008 (T+90)
25,000 shares@ US$0.69Common StockSEC:0001193805-08-001387:0
Canonical exit: 14 Aug 2008 (T+90)
12,500 shares@ US$0.639Common StockSEC:0001193805-08-001388:0
Canonical exit: 14 Aug 2008 (T+90)
175,000 shares0Common StockSEC:0001181431-08-019932:0
4,000 shares@ US$1.16Common StockSEC:0000908662-08-000015:0
2,100 shares@ US$1.10Common StockSEC:0000908662-08-000014:0
1,000 shares@ US$1.15Common StockSEC:0000908662-08-000014:1
2,000 shares@ US$1.14Common StockSEC:0000908662-08-000014:2
900 shares@ US$1.10Common StockSEC:0000908662-08-000014:3
1,000 shares@ US$1.22Common StockSEC:0000908662-07-000446:0
4,000 shares@ US$1.20Common StockSEC:0000908662-07-000446:1
5,000 shares@ US$1.15Common StockSEC:0000908662-07-000446:2
8,500 shares@ US$1.10Common StockSEC:0000908662-07-000380:0
500 shares@ US$1.11Common StockSEC:0000908662-07-000380:1
500 shares@ US$1.15Common StockSEC:0000908662-07-000380:2
500 shares@ US$1.16Common StockSEC:0000908662-07-000380:3
2,500 shares@ US$0.63Common StockSEC:0000950172-06-000572:0
Canonical exit: 15 Mar 2007 (T+90)
7,500 shares@ US$0.64Common StockSEC:0000950172-06-000572:1
Canonical exit: 15 Mar 2007 (T+90)
25 of 45 declarations
About Neurologix Inc/de
Neurologix Inc is a NASDAQ-listed company focused on developing gene therapies for neurological disorders. The company aims to provide innovative solutions to enhance patients' quality of life.
